Location History:
- Latham, NY (US) (2019)
- Niskayuna, NY (US) (2022)
Company Filing History:
Years Active: 2019-2022
Title: Innovations by Chrystal Mae Chadwick
Introduction
Chrystal Mae Chadwick is a notable inventor based in Latham, NY (US). She has made significant contributions to the field of immunology, particularly in the activation of immune cells. With a total of two patents to her name, her work has the potential to impact therapeutic approaches in various medical applications.
Latest Patents
Chrystal's latest patents focus on methods and kits for cell activation. The first patent describes methods of activating immune cells by providing a population of immune cells and contacting them with a first agent and a second agent. The first agent includes an immune cell activator attached to a first binder moiety, while the second agent comprises at least one capture oligomer capable of associating with the first binder moiety. The second patent also involves methods and kits for activating T cells. This method includes providing a population of T cells, adding a plurality of first agents that comprise a T-cell activator and a first binder moiety, and incorporating a second agent with capture oligomers that can associate with the first binder moiety. The process culminates in the incubation of the T cells, leading to their activation.
Career Highlights
Throughout her career, Chrystal has worked with prominent companies such as General Electric Company and Global Life Sciences Solutions USA LLC. Her experience in these organizations has contributed to her expertise in the field of life sciences and immunology.
Collaborations
Chrystal has collaborated with notable professionals in her field, including Ernest William Kovacs and Anup Sood. These collaborations have likely enriched her research and development efforts.
Conclusion
Chrystal Mae Chadwick's innovative work in cell activation showcases her dedication to advancing medical science. Her patents reflect her commitment to improving immune cell functionality, which could lead to significant advancements in therapeutic strategies.